Kurzvorträge, dgpt 2014, 25.02.14.xls
Kurzvorträge
Die Vortragssprache richtet sich nach der Fachgesellschaft.
Calcium channels
Jörg Striessnig (Innsbruck)
First author
City, Country
Agonist evoked Ca2+ elevation in mast 314
Transporter
Birgitta Burckhardt (Göttingen)
First author
City, Country
severe leukopenia, strongly reduces ABCC11 transport activity
in vitro
cotransporter 3 (NaDC3) and of the organic anion transporter 1 (OAT1)
Protein kinases
Tatiana Syrovets (Ulm)
First author
City, Country
pathway, G2 cell cycle arrest, and apoptosis in chemoresistant prostate cancer cells
Cyclic Nucleotides
Slava Nikolaev (Göttingen)
First author
City, Country
characterization and first
in vivo
receptor-microdomain communication in cardiac hypertrophy
Bacterial toxins
Jan Hengstler (Dortmund) and Wim Wätjen (Halle)
First author
City, Country
Enzyme-deficient C3-E174Q from
C.
cyclophilins and FK506-binding proteins for membrane translocation
Clostridium difficile toxin B induces
Clostridium perfringens TpeL toxin
indicates a two-receptor model of clostridial glycosylating toxins
Oxidative and radiation stress
Cornelia Dietrich (Mainz)
First author
City, Country
against genotoxic stress in the
in vivo model organism
C. elegans
factor Nrf2 in kidney cells both
in vitro
Caenorhabditis elegans by baicalein derivatives
Cardiovascular system
Justus Stenzig (Hamburg)
First author
City, Country
Effects of maternal PETN treatment of 468
Toxic substances and metabolism
Charlotte Esser (Düsseldorf) and Albert Braeuning (Tübingen)
First author
City, Country
cytochrome P450 1A1 yielding glutathione and protein adducts
Formation of cytotoxic benzo[
a ]pyrene- 183
Green tea and one of its constituents, 289
inhibitors of human 11β-hydroxysteroid dehydrogenase type 1
Toxic substances
Helga Stopper (Würzburg)
First author
City, Country
Correlation between
in-vivo and
in-
vitro combination effects of triazole
fungicides in the adrenal gland and H295R cells
Ludwigshafen, Testing mixtures
in vivo at human-
Velocity of the release of free cyanide 484
cyanogenic glycosides after tissue destruction as important factor determining their toxicity
Small and heterotrimeric G proteins
Joachim Orth (Freiburg)
First author
City, Country
Enhanced sensitivity of phospholipase 293
lymphocytic leukaemia resistance to the Bruton´s tyrosine kinase inhibitor ibrutinib
in vivo
Pasteurella multocida toxin stimulates 217
osteoclast differentiation by activation
Central nervous system
Marion Bankstahl (Hannover)
Immunopharmacology (I)
Martina Schmidt (Groningen, NL)
First author
City, Country
aeruginosa , a bacterium critical to cystic fibrosis patients
PLAID, a novel form of human hereditary antibody deficiency and immune dysregulation
Immunopharmacology (II)
Detlef Neumann (Hannover)
phosphate enhancesCOX-2 expression and migration in human monocytes
remodeling processes induced by cigarette smoke
GPCRs (I)
Martin Göttle, Hannover (Germany)
First author
City, Country
receptor binding in hematopoietic cells from rat spleen and bone marrow?
Quantifying ligand bias of enantiopure 166
GPCRs (II)
Andreas Bock (Würzburg)
Genetic dissection of plexin signalling 165
Differential participation of Gβγ in the
Clinical Pharmacology (I)
Jens Tank (Hannover)
First author
City, Country
and metabolism in obese hypertensive patients
the worldwide genetic variability in the
OCT1 gene?
and mir-132. Results from a genomewide miRNA screen in focal and non-focal brain tissue of therapy-resistant epilepsy patients.
Clinical Pharmacology (II)
Renke Maas (Erlangen)
Eleutherococcus senticosus , radix,
with respect to its safety in hypertensive patients
improving medication safety in ambulatory care
Mutagenesis, carcinogenesis and cancer
Gerhard Fritz (Mainz) and Nicole Schupp (Würzburg)
First author
City, Country
cellular senescence in human peritoneal mesothelial LP9 cells
dynamics in human keratinocytes with distinctive effects on genotoxicity
highly expressed genes which are characterized by topoisomerase IIα enrichment at promoters
ErbB3 in the nucleus – mechanisms of 432
Implications for their carcinogenic mode of action
methyltransferase (MGMT)
in vitro and in colorectal cancer cells
Source: http://www.dgpt2014.de/app/download/8605289894/Kurzvortr%C3%A4ge,+DGPT+2014,+25.02.14.pdf?t=1393346684
0022-3565/00/2942-0510$03.00/0THE JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICSCopyright © 2000 by The American Society for Pharmacology and Experimental TherapeuticsHydroxyprolylserine Derivatives JBP923 and JBP485 Exhibitthe Antihepatitis Activities after Gastrointestinal Absorption inRats1KE-XIN LIU, YUKIO KATO, TAI-ICHI KAKU, TOMOFUMI SANTA, KAZUHIRO IMAI, AKIRA YAGI, TAKASHI ISHIZ
11th NAPRECA Symposium Book of Proceedings, Antananarivo, Madagascar Natural Products and Drug Discovery through a Network of Partnerships Philippe Rasoanaivo, David Ramanitrahasimbola, Dina Rakotondramanana, Voahangy Ramanandraibe, Suzanne Ratsimamanga Institut Malgache de Recherches Appliquées Abstract We present here relevant result obtained from a network of collaborations. Mala